EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Assessment of Neurodevelopment in Infants With and Without Exposure to Asymptomatic or Mild Maternal SARS-CoV-2 Infection During Pregnancy

Morgan R Firestein, Lauren C Shuffrey, Yunzhe Hu, Margaret Kyle, Maha Hussain, Catherine Bianco, Violet Hott, Sabrina P Hyman, Mia Kyler, Cynthia Rodriguez, Melanie Tejeda Romero, Helen Tzul Lopez und 37 weitere

JAMA Network Open · 10.04.2023 · 6 (4) · e237396

DOI: 10.1001/jamanetworkopen.2023.7396 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift JAMA Network Open, online erschienen am 10.04.2023. Verfasst von Morgan R Firestein und 48 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Columbia University Irving Medical Center, New York, New York. Hauptthemen laut MEDLINE: COVID-19, Prenatal Exposure Delayed Effects, Pregnancy Complications, Infectious. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Associations between prenatal SARS-CoV-2 exposure and neurodevelopmental outcomes have substantial public health relevance. A previous study found no association between prenatal SARS-CoV-2 infection and parent-reported infant neurodevelopmental outcomes, but standardized observational assessments are needed to confirm this finding.

Objective

To assess whether mild or asymptomatic maternal SARS-CoV-2 infection vs no infection during pregnancy is associated with infant neurodevelopmental differences at ages 5 to 11 months. Design, Setting, and Participants This cohort study included infants of mothers from a single-site prospective cross-sectional study (COVID-19 Mother Baby Outcomes [COMBO] Initiative) of mother-infant dyads and a multisite prospective cohort study (Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 in Pregnancy and Infancy [ESPI]) of pregnant individuals. A subset of ESPI participants was subsequently enrolled in the ESPI COMBO substudy. Participants in the ongoing COMBO study were enrolled beginning on May 26, 2020; participants in the ESPI study were enrolled from May 7 to November 3, 2021; and participants in the ESPI COMBO substudy were enrolled from August 2020 to March 2021. For the current analysis, infant neurodevelopment was assessed between March 2021 and June 2022. A total of 407 infants born to 403 mothers were enrolled (204 from Columbia University Irving Medical Center in New York, New York; 167 from the University of Utah in Salt Lake City; and 36 from the University of Alabama in Birmingham). Mothers of unexposed infants were approached for participation based on similar infant gestational age at birth, date of birth, sex, and mode of delivery to exposed infants. Exposures Maternal symptomatic or asymptomatic SARS-CoV-2 infection. Main Outcomes and Measures Infant neurodevelopment was assessed using the Developmental Assessment of Young Children, second edition (DAYC-2), adapted for telehealth assessment. The primary outcome was age-adjusted standard scores on 5 DAYC-2 subdomains: cognitive, gross motor, fine motor, expressive language, and receptive language.

Results

Among 403 mothers, the mean (SD) maternal age at delivery was 32.1 (5.4) years; most mothers were of White race (240 [59.6%]) and non-Hispanic ethnicity (253 [62.8%]). Among 407 infants, 367 (90.2%) were born full term and 212 (52.1%) were male. Overall, 258 infants (63.4%) had no documented prenatal exposure to SARS-CoV-2 infection, 112 (27.5%) had confirmed prenatal exposure, and 37 (9.1%) had exposure before pregnancy or at an indeterminate time. In adjusted models, maternal SARS-CoV-2 infection during pregnancy was not associated with differences in cognitive (β = 0.31; 95% CI, −2.97 to 3.58), gross motor (β = 0.82; 95% CI, −1.34 to 2.99), fine motor (β = 0.36; 95% CI, −0.74 to 1.47), expressive language (β = −1.00; 95% CI, −4.02 to 2.02), or receptive language (β = 0.45; 95% CI, −2.15 to 3.04) DAYC-2 subdomain scores. Trimester of exposure and maternal symptom status were not associated with DAYC-2 subdomain scores. Conclusions and Relevance In this study, results of a novel telehealth-adapted observational neurodevelopmental assessment extended a previous finding of no association between prenatal exposure to maternal SARS-CoV-2 infection and infant neurodevelopment. Given the widespread and continued high prevalence of COVID-19, these data offer information that may be helpful for pregnant individuals who experience asymptomatic or mild SARS-CoV-2 infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Prenatal Exposure Delayed EffectsPregnancy Complications, InfectiousInfant, NewbornChildFemalePregnancyHumansInfantMaleChild, PreschoolAdultCohort StudiesProspective StudiesCross-Sectional StudiesSARS-CoV-2

Autor:innen und Institutionen

  • Department of Psychiatry, Columbia University Irving Medical Center, New York, New York.
  • Department of Pediatrics, Columbia University Irving Medical Center, New York, New York.
  • Department of Psychology, Columbia University, New York, New York.
  • School of Social Work, Columbia University, New York, New York.
  • Heilbrunn Department of Population and Family Health, Columbia University Irving Medical Center, New York, New York.
  • Department of Neurology, Division of Child Neurology, Columbia University Irving Medical Center, New York, New York.

Förderung

  • NIMH NIH HHS

Zitieren

APA

Firestein, M. R., Shuffrey, L. C., Hu, Y., Kyle, M., Hussain, M., Bianco, C., Hott, V., Hyman, S. P., Kyler, M., Rodriguez, C., Tejeda Romero, M., Tzul Lopez, H., Alcántara, C., Amso, D., Austin, J., Bain, J. M., Barbosa, J., Battarbee, A. N., Bruno, A., …, & Dumitriu, D. (2023). Assessment of Neurodevelopment in Infants With and Without Exposure to Asymptomatic or Mild Maternal SARS-CoV-2 Infection During Pregnancy. JAMA Network Open, 6(4), e237396. https://doi.org/10.1001/jamanetworkopen.2023.7396

Vancouver

Firestein MR, Shuffrey LC, Hu Y, Kyle M, Hussain M, Bianco C, et al. Assessment of Neurodevelopment in Infants With and Without Exposure to Asymptomatic or Mild Maternal SARS-CoV-2 Infection During Pregnancy. JAMA Network Open. 2023;6(4):e237396. doi:10.1001/jamanetworkopen.2023.7396

BibTeX
@article{Firestein2023,
  author = {Firestein, Morgan R and Shuffrey, Lauren C and Hu, Yunzhe and Kyle, Margaret and Hussain, Maha and Bianco, Catherine and Hott, Violet and Hyman, Sabrina P and Kyler, Mia and Rodriguez, Cynthia and Tejeda Romero, Melanie and Tzul Lopez, Helen and Alcántara, Carmela and Amso, Dima and Austin, Judy and Bain, Jennifer M and Barbosa, Jennifer and Battarbee, Ashley N and Bruno, Ann and Ettinger, Sharon and Factor-Litvak, Pam and Gilboa, Suzanne and Goldman, Sylvie and Gyamfi-Bannerman, Cynthia and Maniatis, Panagiotis and Marsh, Rachel and Morrill, Tyler and Mourad, Mirella and Muhle, Rebecca and Newes-Adeyi, Gabriella and Noble, Kimberly G and O'Reilly, Kally C and Penn, Anna A and Reichle, Lawrence and Sania, Ayesha and Semenova, Vera and Silver, Wendy G and Smotrich, Grace and Tita, Alan T and Tottenham, Nim and Varner, Michael and Welch, Martha G and Zork, Noelia and Garey, Donna and Fifer, William P and Stockwell, Melissa S and Monk, Catherine and Dawood, Fatimah and Dumitriu, Dani},
  title = {Assessment of Neurodevelopment in Infants With and Without Exposure to Asymptomatic or Mild Maternal SARS-CoV-2 Infection During Pregnancy},
  journal = {JAMA Network Open},
  year = {2023},
  volume = {6},
  number = {4},
  pages = {e237396},
  doi = {10.1001/jamanetworkopen.2023.7396}
}
Kostenlos starten →